The Latest News from BioAgilytix

BioAgilytix Appoints Two New Scientific Officers

Durham, NC, May 4, 2022 – BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development, has appointed two…

Read More

Serving the growing biotechnology community

Read More

Cinven Completes Majority Investment in BioAgilytix

Investment will Power Further Expansion of Core Business and Drive Future Growth of the Company  December 21, 2021—Durham, NC, USA and London, UK—BioAgilytix, a leading global contract research organization (CRO),…

Read More

BioAgilytix Secures Significant New Investment from Global Investor Cinven to Fuel Continued Long-Term Growth

Investment Will Provide BioAgilytix with Additional Resources to Invest in Core Business and Drive GrowthNovember 17, 2021—Durham, NC, USA, Brussels, Belgium and London, UK—BioAgilytix, a leading global contract research organization…

Read More

BioAgilytix Closes Acquisition of Australia-based 360biolabs®

Following final government approval, 360biolabs, a BioAgilytix company, adds world-class virology & immunology expertise and LC/MS/MS small molecule capabilities to the company, enabling support of bioanalytical services across all geographies…

Read More

BioAgilytix Announces New Partnership With CTI

Alliance to strengthen both companies’ ability to provide a seamless, full-service bioanalytical client experience across the full spectrum of lifecycle developmentDurham, NC, October 4, 2021 – BioAgilytix Labs, LLC (BioAgilytix), a leading…

Read More

For the 8th Time, BioAgilytix Named to Inc. 5000 Annual List of America’s Fastest-Growing Private Companies

Ranked No. 1939, With 3-Year Revenue Growth of 230 Percent DURHAM, NC, August 25, 2021 – BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research organization focused on supporting pharmaceutical…

Read More

MicroConstants to Join BioAgilytix Family

Highly complementary transaction strengthens BioAgilytix’s ability to support bioanalytical services across all major therapeutics in development; adds LC/MS/MS capabilities; and expands team of seasoned scientistsDurham, NC, August 18, 2021 –…

Read More

BioAgilytix to Purchase Australia-based 360biolabs®

Highly complementary transaction will strengthen company’s ability to support bioanalytical services across all stages, development capabilities and geographiesDurham, NC, August 16, 2021 – BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused…

Read More